Chronic Kidney disease is a severe lifelong condition caused either by renal disease or by impaired functions of the kidneys. In the present area of research, Kidney cancer is one of the deadliest and crucial importance for the survival of the patients ’ diagnosis and classification. Early diagnosis and proper therapy can stop or delay the development of this chronic disease into the final stage where dialysis or renal transplantation is the only way of saving the life of the patient. The development of automated tools to accurately identify subtypes of kidney cancer is, therefore, an urgent challenge in the recent past. In this paper, to examine the ability of various deep learning methods an Adaptive hybridized Deep Convolutional Neural Network (AHDCNN) has been proposed for the early detection of Kidney disease efficiently and effectively. Classification technology efficiency depends on the role of the data set. To enhance the accuracy of the classification system by reducing the feature dimension an algorithm model has been developed using CNN. These high-level properties help to build a supervised tissue classifier that discriminates between the two types of tissue. The experimental process on the Internet of medical things platform (IoMT)concludes, with the aid of predictive analytics, that advances in machine learning which provides a promising framework for the recognition of intelligent solutions to prove their predictive capability beyond the field of kidney disease.
19 December 2017 in Journal of Zhejiang University-SCIENCE B
The cases of donation after brain death followed by circulatory death (DBCD) and donation after cardiac death (DCD) have been increased year by year in China. Further research is needed to understand in the outcomes and risk factors of delayed graft function (DGF) in order to minimize the risk of DGF and ameliorate its potential impact on long-term outcomes. This study was to explore the differences in outcomes between DBCD and DCD transplant and the main risk factors for DGF in DBCD. Retrospective analysis of the clinical data of 367donations after citizens’ death kidney transplant procedures (donors and recipients) between July 2012 and August 2015 at our center. During the study period, the donation success rate was 25.3%. 164 cases of DBCD and 35 cases of DCD had been implemented and 367 kidneys were transplanted. The incidence of DGF in DBCD group were significantly lower than that of DCD group (12.0% vs. 27.0%, p = 0.002). The 1-year percent freedom from acute rejection (AR) was significantly higher in DBCD group compared with it of DCD group (94% vs. 82%, p = 0.036). Multivariate logistic regression analysis of the kidney transplants revealed that the high risk factors for DGF after renal transplantation in DBCD were history of hypertension (Odds Ratio [OR] = 5.88, 95% CI: 1.90 to 18.2, p = 0.002), low blood pressure (BP < 80 mmHg) (OR = 4.86, 95% CI: 1.58 to 14.9, p = 0.006) and serum creatinine of donor (OR = 1.09, 95% CI: 1.03 to 1.16, p = 0.003) before donation. The outcomes of DBCD could be better than DCD in DGF and AR. The main risk factors for DGF in DBCD kidney transplants are donors with a history of hypertension, low blood pressure, and serum creatinine of donor before donation.